About High Intensity Focused Ultrasound
Indications
The Benefits of Sonablate HIFU
New Prostate Cancer Treatment
The Sonablate 500 Non-Invasive Option
Hospital Stay

Latest Results

Complications
point is non-invasive point has no blood loss
point is effective point is nerve sparing
point requires no incision point is painless

 

Dr Alistair Cameron-Strange
MbChb, FRCSEd, FRACS (Urol).

Telephone: (02) 9650 4973

Suite 23, Level 7,
The Prince of Wales Private Hospital, Barker St, Randwick
Sydney. NSW. 2031.

Email:

Dr Dr Hodo Haxhimolla
MBBS, FRACS (Urol).

Telephone: (02) 6281 7900

Suite 6,
The National Capital Private Hospital, Canberra.

Email:


Focus Surgery, Inc. - www.focus-surgery.com

Focus Surgery is a pioneer in the development and commercialisation of products using High Intensity Focused Ultrasound (HIFU) for the treatment of prostate diseases. Based in Indianapolis, Indiana, Focus Surgery designs and manufactures the Sonablate® 500 system, an image-guided acoustic ablation device. Doctors worldwide have already successfully treated thousands of prostate cancer and BPH patients using the Sonablate® 500.

THS International, Inc. - www.thsinternational.com

THS International is involved in the worldwide effort to promote the use of HIFU for the treatment of prostate diseases with Urologists and patients alike. THS International is committed to improving the quality of life for patients that are faced with the decision of treating cancer. THS International founded, and remains a major shareholder of Focus Surgery, Inc., a HIFU medical device company based in Indianapolis, Indiana.

International HIFU Centers - www.internationalhifu.com

Information for both patients and physicians on High Intensity Focused Ultrasound (HIFU) - a non-invasive prostate cancer treatment that minimises side effects and preserves patient quality of life.
Copyright © HIFUSYDNEY, 2006. All rights reserved. Site developed by Premier Web Services.